topical glycopyrronium 2% avoids unwanted anticholinergic effects associated with systemic anticholinergics
F - reduces the risk but can still occur. majority occur within first week of tx and decrease over time
JAAD Jan 19
Beneficial effects of topical glycopyrronium are delayed until week 4 of application
F - see effects within first week of application